DiviDrip · EBS

EBS — Emergent BioSolutions Inc.

EBS is Emergent BioSolutions Inc. (Healthcare) — a non-dividend-paying stock. Trading at $6.21. Market cap: $319M. Capital Quality Rank: 49/100 — Stagnant mediocrity.

Stock snapshot

Price$6.21
Market cap$319M
SectorHealthcare
ExchangeNYQ
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)49 / 100 · Stagnant mediocrity
ROIC (TTM)8.9%
Revenue CAGR (3y)-12.7%
Shareholder buyback yield-6.53%
Altman Z-score zoneDistress

About EBS

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Listed2006Employees900HQGaithersburg, MDSectorHealthcareWebsiteemergentbiosolutions.com

Related non-dividend companies

Other non-dividend stocks investors research alongside EBS. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is EBS's current stock price?

EBS (Emergent BioSolutions Inc.) is currently trading at $6.21.

Does EBS pay a dividend?

EBS (Emergent BioSolutions Inc.) does not currently pay a regular dividend.

What is EBS's Capital Quality Rank?

EBS has a Capital Quality Rank of 49/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track EBS in DiviDrip

Add EBS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow